Skip to main content

MetLife Investment Management, LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1529735 Whippany, NJ

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$793,322
+$348,097 QoQ
Shares Held
100,167
+30.5% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 238 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. XERS ranks #21 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $793,322 100,167
2026-03-31 $445,225 76,763
2025-03-31 $448,911 81,769
2024-12-31 $296,394 87,432
2024-09-30 $168,742 59,208
2024-06-30 $185,935 82,638
2024-03-31 $128,383 58,092
2023-12-31 $167,406 71,237
2023-09-30 $132,500 71,237
2023-03-31 $116,116 71,237
2022-12-31 $34,352 25,829
2022-09-30 $110,532 70,854
2022-06-30 $109,115 70,854